Helix

Verily launches Viewpoint Workbench to unify data and accelerate biomedical research

Retrieved on: 
Thursday, October 5, 2023

Verily, an Alphabet precision health technology company, has launched Viewpoint Workbench, a new enterprise-grade platform to unify multimodal data and accelerate biomedical research.

Key Points: 
  • Verily, an Alphabet precision health technology company, has launched Viewpoint Workbench, a new enterprise-grade platform to unify multimodal data and accelerate biomedical research.
  • Workbench provides a secure collaborative environment for data generators, research, and biopharma organizations to govern and analyze their data.
  • Data generating organizations, research sponsors, and biomedical researchers can use Workbench to securely connect with stakeholders and partners, explore and analyze multimodal data, and simplify data governance with access control and policy enforcement.
  • Workbench users can tap into a growing ecosystem of data sources and researchers, to build on collective scientific progress, share best practices, and conduct reproducible research.

Helix Helps Wysh Deliver New High-Yield Savings Account with Embedded Micro Life Insurance

Retrieved on: 
Thursday, October 5, 2023

Savings+, Wysh’s new product, couples high-yield savings with life insurance without the need for underwriting and works to help underserved communities gain insurance protection at no cost.

Key Points: 
  • Savings+, Wysh’s new product, couples high-yield savings with life insurance without the need for underwriting and works to help underserved communities gain insurance protection at no cost.
  • Wysh’s dedication to serving underprivileged Americans has resulted in the launch of this new high-yield savings account paired with no-cost life insurance.
  • Savings+ offers a 4.00 percent Annual Percentage Yield rate* and can unlock up to $10,000 in no-cost life insurance**.
  • Savings+ offers peace of mind for account holders whose beneficiaries would receive up to an additional 10 percent of life insurance value on top of their savings account balance in the form of a life insurance payout.

BMC Is First to Embed GPT Across AI-Driven Service and Operations Management Portfolio

Retrieved on: 
Wednesday, October 11, 2023

HOUSTON, Oct. 11, 2023 /PRNewswire/ -- BMC, a global leader in software solutions for the Autonomous Digital Enterprise, today announced the expansion of its generative AI capabilities, embedding them into its entire AI-driven service and operations management portfolio—the first vendor in the industry to do so. The BMC HelixGPT solution connects and distills data sources across the enterprise to deliver plain-language, actionable insights for autonomous resolution by connecting AIOps, DevOps, and ServiceOps.

Key Points: 
  • It integrates information across the BMC Helix Digital Workplace, BMC Helix Knowledge Management, and BMC Helix Virtual Agent solutions.
  • Resolution insights—Ingests all enterprise data, including historical and current case data, across enterprise service management and IT operations management to determine a more optimized process.
  • In addition, it can use combined operations and service management ticket data to make best-action recommendations.
  • "BMC is the first vendor to offer generative AI use cases purpose-built for IT service and operations teams to analyze vast amounts of data," said Margaret Lee, senior vice president and general manager of Digital Service and Operations Management at BMC.

WellSpan Health Bond Rating Affirmed by Agencies as Stable

Retrieved on: 
Tuesday, October 3, 2023

York, Pa., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Affirmed by Moody’s Investor Services (Moody’s) and Fitch Ratings, WellSpan Health today announced stable bond ratings, maintaining a leading position in South Central Pennsylvania and allowing the health system to continue providing the highest quality care at the lowest cost to patients.

Key Points: 
  • York, Pa., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Affirmed by Moody’s Investor Services (Moody’s) and Fitch Ratings, WellSpan Health today announced stable bond ratings, maintaining a leading position in South Central Pennsylvania and allowing the health system to continue providing the highest quality care at the lowest cost to patients.
  • Moody’s affirmed the “Aa3” and “Aa3/VMIG 1 revenue bonds” rating for the third year in a row while Fitch affirmed their AA- rating.
  • “The continued efforts to maintain our health system’s financial performance is affirmed through these bond ratings and attests to WellSpan’s leading position in South Central Pennsylvania,” said Laura Buczkowski, executive vice president and chief financial officer, WellSpan Health.
  • WellSpan continues to enhance existing infrastructure as well, including the continued expansion at WellSpan York Hospital using sustainable solutions , and expanding services such as the organization’s comprehensive behavioral health network demonstrate a focus on supporting the health of area communities.

Securonix Appoints Al Arun as Chief Customer Officer

Retrieved on: 
Tuesday, October 3, 2023

Securonix, Inc. , a leader in Unified Defense SIEM, today announced the appointment of Al Arun as Chief Customer Officer.

Key Points: 
  • Securonix, Inc. , a leader in Unified Defense SIEM, today announced the appointment of Al Arun as Chief Customer Officer.
  • “We are excited to welcome Al Arun to the executive leadership team at Securonix,” said Nayaki Nayyar, Chief Executive Officer, Securonix.
  • “Al has a well-established track record of cultivating customer success and driving customer experience and value with cloud and SaaS-based technologies that are well-aligned with our short- and long-term vision.
  • Arun most recently served as the Chief Customer Officer of Ivanti, where he led the global professional services, customer value, customer success, support and education organizations.

Tomorrow and Half Helix Announce Merger to Create Largest Independent Partner Serving Shopify Enterprise Brands

Retrieved on: 
Wednesday, September 27, 2023

BOSTON, Sept. 27, 2023 /PRNewswire/ -- Leading Shopify Plus platform service partners Tomorrow and Half Helix today announced a merger of the two companies that creates the largest independent pure play Shopify service partner in the world.

Key Points: 
  • BOSTON, Sept. 27, 2023 /PRNewswire/ -- Leading Shopify Plus platform service partners Tomorrow and Half Helix today announced a merger of the two companies that creates the largest independent pure play Shopify service partner in the world.
  • Half Helix ( www.halfhelix.com ) was started in 2015 to build, grow and guide the next generation of e-commerce companies on the Shopify Plus platform.
  • Founded in 2019, Tomorrow ( www.tomorrowagency.com ) is a digital transformation partner that brings enterprise experience to the Shopify Plus ecosystem.
  • Matt Kinsey, Managing Partner of BV, said, "Both Half Helix and Tomorrow are leaders that drive value to Shopify, their merchants and brands."

DZS Secures $29.7 Million in Financing

Retrieved on: 
Wednesday, September 13, 2023

DALLAS, Sept. 13, 2023 (GLOBE NEWSWIRE) -- DZS (Nasdaq: DZSI), a global leader of access, optical and AI-driven cloud software solutions, today announced it has secured $29.7 million in loans, including a $24.5 million 3-year term loan with 29% shareholder DASAN Networks, Inc. (DNI).

Key Points: 
  • DALLAS, Sept. 13, 2023 (GLOBE NEWSWIRE) -- DZS (Nasdaq: DZSI), a global leader of access, optical and AI-driven cloud software solutions, today announced it has secured $29.7 million in loans, including a $24.5 million 3-year term loan with 29% shareholder DASAN Networks, Inc. (DNI).
  • The 3-year $24.5 million term loan with an annual interest rate of 8% complements approximately $5.2 million of short-term loans with South Korean bank financial partners.
  • The cash will be used to pay off DZS’ existing term debt facility and line of credit.
  • DNI is encouraged with the company’s future prospects and remains committed to support DZS.

Altria Seeks Importation Ban of JUUL E-Vapor Products; Files Patent Infringement Actions Against JUUL Labs

Retrieved on: 
Tuesday, August 22, 2023

Altria Group, Inc. (NYSE: MO) today announces that its subsidiary, NJOY, has filed a complaint against JUUL Labs, Inc. (JUUL) with the U.S. International Trade Commission (ITC).

Key Points: 
  • Altria Group, Inc. (NYSE: MO) today announces that its subsidiary, NJOY, has filed a complaint against JUUL Labs, Inc. (JUUL) with the U.S. International Trade Commission (ITC).
  • The complaint seeks a ban on the importation and sale of certain JUUL e-vapor products, including its currently marketed JUUL device and JUULpods.
  • “Protecting our intellectual property is critical to achieving our Vision,” said Murray Garnick, Executive Vice President and General Counsel.
  • NJOY acquired the Asserted Patents from Fuma International, LLC (Fuma) concurrently with the settlement of a patent infringement lawsuit filed against us by Fuma.

Helix and Nebraska Medicine Partner to Provide Precision Care in Nebraska to Help Find Health Issues Individually and Statewide

Retrieved on: 
Tuesday, August 15, 2023

"The Genetic Insights Project is a fundamental step in being able to provide patients with precision care.

Key Points: 
  • "The Genetic Insights Project is a fundamental step in being able to provide patients with precision care.
  • "This information will let people make proactive decisions about their own health," says Kyle Skiermont, PharmD, Nebraska Medicine vice president of operations.
  • Nebraska Medicine joins other health systems nationwide in partnering with Helix to launch this program.
  • Nebraska Medicine and Helix plan to officially launch it on a limited basis in late 2023.

BioCardia Reports Second Quarter 2023 Business Highlights and Financial Results

Retrieved on: 
Wednesday, August 9, 2023

SUNNYVALE, Calif., Aug. 09, 2023 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reports financial results for the second quarter of 2023 and filed its quarterly report on Form 10-Q for the three and six months ended June 30, 2023 with the Securities and Exchange Commission.

Key Points: 
  • SUNNYVALE, Calif., Aug. 09, 2023 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reports financial results for the second quarter of 2023 and filed its quarterly report on Form 10-Q for the three and six months ended June 30, 2023 with the Securities and Exchange Commission.
  • The Company will also hold a conference call at 4:30 PM ET today in which it will discuss business highlights.
  • On July 12, 2023, the planned Data Safety Monitoring Board (DSMB) meeting was held utilizing the adaptive statistical analysis plan reviewed by FDA in the second quarter.
  • Second Quarter 2023 Financial Results:
    Revenues were approximately $43,000 for the three months ended June 2023, compared to approximately $974,000 in the three months ended June 2022, due primarily to the timing of collaboration agreement revenues.